Skip to content

Psychedelic-assisted therapy: all studies

Page 213 of 294: studies 2,121 to 2,130 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Milan Hausner, the Sadská Clinic, and The Fate of LSD Psychotherapy in Communist Czechoslovakia

The MIT Press eBooks November 21, 2023 Ross Crockford 1 citation

Hausner originally doubted that she could be helped.But as he listened to a recording of Hana's third LSD session, he saw some hope."The most pronounced aspect of this session is her archetypal regression into the realm of antiquity and to the very beginnings of humanity," Hausner later wrote. 1 "Hana is beginning to formulate a new attitude toward death and eternity."Over the next six months,...

From Psychiatric Clinics to Magical Center: LSD in the Netherlands

The MIT Press eBooks November 21, 2023 Stephen Snelders 1 citation

Dutch psychedelic history had its own characteristics. In psychiatry, LSD therapy was used for the management of the traumas of World War II; in Dutch society, overlapping groups of activists and psychedelics users were involved in a playful transformation of society into a “Magical Center”; and in economics, the Netherlands became a key player in the illegal production and distribution of LSD...

DOI: 10.7551/mitpress/14417.003.0023 (opens in new tab) Full text (opens in new tab) Center category theory Magical thinking Alternative medicine

Psychedelics in Israel: A Brief History

The MIT Press eBooks November 21, 2023 Ido Hartogsohn, Itamar Zadoff 2 citations

As of 2021, Israel is positioned at the forefront of a global revival of psychedelic research and culture.The small Middle Eastern country hosts clinical trials with psychedelics, generates multiple psychedelic start-ups, and hosts a pioneering psychedelic therapy training program.Popu lar interest in psychedelics is surging throughout the country as well, with multiple conferences, podcasts,...

News Brief: MDMA therapy for PTSD.

AJN, American Journal of Nursing November 21, 2023

MDMA therapy for PTSD. Those suffering from posttraumatic stress disorder (PTSD) may have a new treatment option—psychedelic therapy. In a confirmatory randomized controlled trial with 104 participants, researchers found that 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy reduced symptoms and functional impairment in people with moderate to severe PTSD. Their findings add to a...

Psychedelia: The interplay of music and psychedelics

Annals of the New York Academy of Sciences November 20, 2023 Katarina Jerotic, Peter Vuust, Morten L. Kringelbach 19 citations

Abstract Music and psychedelics have been intertwined throughout the existence of Homo sapiens , from the early shamanic rituals of the Americas and Africa to the modern use of psychedelic‐assisted therapy for a variety of mental health conditions. Across such settings, music has been highly prized for its ability to guide the psychedelic experience. Here, we examine the interplay between music...

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders

Journal of Medicinal Chemistry November 20, 2023 Kaveh Matinkhoo, Lisa Yu, David Press et al. 18 citations

The psychedelic prodrug psilocybin has shown therapeutic benefits for the treatment of numerous psychiatric conditions. Despite positive clinical end points targeting depression and anxiety, concerns regarding the duration of the psychedelic experience produced by psilocybin, associated with enduring systemic exposure to the active metabolite psilocin, pose a barrier to its therapeutic...

Does LSD Have Any Therapeutical Value In Mental Disorders? A Non-Systemic Review

European Psychiatry November 17, 2023 L. Silva, L. Bravo 1 citation

Introduction Lysergic acid diethylamide (LSD) a semi synthetic hallucinogen, was first synthetized by Albert Hofmann in 1938 and its psychological properties were not discovered until 1943. There was a brief renaissance of its use in psychiatry, specifically in assisted psychotherapy for the treatment of alcoholism, neurosis and psychosomatic disorders. However, research with LSD and others...

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol

European Psychiatry November 17, 2023 M. I. Husain, Daniel M. Blumberger, David Castle et al.

Introduction During the last decade there has been a resurgence of interest on the use of psychedelics as novel treatments for mental disorders, including treatment-resistant depression (TRD). Psilocybin, the chemical component of “magic mushrooms”, has been administered with psychotherapy in randomized clinical trials (RCTs) showing large and sustained antidepressant effects. As the use of...

Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness

Journal of Psychedelic Studies November 16, 2023 Danelle Jones 48 citations

Recent years have seen a global explosion in the field of psychedelic research, popularizing of use of non-ordinary states of consciousness to aid in PTSD, anxiety and depression, end of life and a growing sense that the use of substances like MDMA, psilocybin and others may become mainstream approaches to treating persistent challenges in these marginalized populations.As we destigmatize these...

Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research.

ACS Chemical Neuroscience November 15, 2023 L Jacob Flameling, Jacob S. Aday, Michiel van Elk

ADVERTISEMENT RETURN TO ARTICLES ASAPPREVViewpointNEXTExpectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy ResearchL. Jacob FlamelingL. Jacob FlamelingInstitute of Psychology, Leiden University, Leiden 2333 AK, The NetherlandsMore by L. Jacob Flamelinghttps://orcid.org/0000-0002-1425-1180, Jacob S. AdayJacob S. AdayDepartment of Anesthesiology, University of Michigan, Ann Arbor,...